Asia-Pacific alopecia areata market is expected to reach USD 4,275.47 million by 2031 from USD 2,034.30 million in 2023, growing with a CAGR of 9.7% in the forecast period of 2024 to 2031. Market Segmentation: Asia-Pacific Alopecia Areata Market, By Disease Type (Alopecia Areata (Patchy), Alopecia Areata Totalis, Alopecia Areata Universalis, and Others), Cause (Non-Genetic and Genetic), Type (Treatment and Diagnosis), Age Group (Below 18 Years, 18-50 Years, and Above 50 Years), Gender (Female and Male), Country (Japan, China, South Korea, Australia, India, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2031 Overview of Asia-Pacific Alopecia Areata Market Dynamics: Driver • Increase in geriatric population Restraint • Side effects associated with the available hair loss treatment therapies Opportunity • Development and technological advancements in hair treatment medical devices Market Players: The key market players operating in the Asia-Pacific alopecia areata market are listed below: • Pfizer Inc. • Dr. Reddy's Laboratories Ltd. • Lilly • Sun Pharmaceutical Industries Ltd. • GSK plc. • Johnson & Johnson Consumer Inc. • Lupin • Croma-Pharma GmbH • Viviscal Limited (A Subsidiary of Church & Dwight Co.) • Wellona Pharma • Teva Pharmaceuticals USA, Inc. • Croma-Pharma GmbH • Vitabiotics Ltd. • Reistone Biopharma • TechnoDerma Medicines Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. This publisher does offer titles that are created upon receipt of order.
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Alopecia Areata Market
Figure 12 Executive Summary Of Asia-pacific Alopecia Areata Market-
Figure 13 Strategic Decisions
Figure 14 Segmental Comparison Of Asia-pacific Alopecia Areata Market
Figure 15 Rise In Prevalence Of Alopecia Conditions, Increase In Prevalence Of Chemotherapy Induced Alopecia, Increasing Level Of Stress And Changing Lifestyles Are Driving The Asia-pacific Alopecia Areata Market In The Forecast Period Of 2024 To 2031
Figure 16 Alopecia Areata (Patchy) Segment Is Expected To Account For The Largest Share Of The Asia-pacific Alopecia Areata Market In 2024 & 2031
Figure 17 Drivers, Restraints, Opportunities And Challenges Of Asia-pacific Alopecia Areata Market
Figure 18 Asia-pacific Alopecia Areata Market: By Type, 2023